May 8, 2024

Green Bay resident becomes first Wisconsinite to receive gene therapy treatment for hemophilia A — WBAY

GREEN BAY, WI — David Novak, a patient at the Hemophilia Outreach Center, made history as the first Wisconsinite — and only the second person in the nation — to receive the newly FDA-approved gene therapy treatment ROCTAVIAN for hemophilia A. This breakthrough offers hope for reducing or eliminating the need for regular infusions and marks a major milestone for the hemophilia community.

Read the full story on WBAY

Recent Posts

Out On The Town: Bleeding Disorders Awareness Edition

In this special episode of Beyond the Bleeds, Heather and John take bleeding disorder awareness beyond the clinic and into the community. From downtown Green Bay to St. Norbert College in De Pere, Wisconsin, they hit the streets to ask everyday people what they know...

Have You Thought About Fiber Lately?

You may have thought about many aspects of your health such as sunscreen, protein, or exercise but one essential nutrient remains grossly underappreciated: dietary fiber. Fiber doesn’t come with flashy marketing or miracle claims, yet its impact on human health is...

Social Media